![Salman Al-Mahmood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Salman Al-Mahmood
Keine laufenden Positionen mehr
Profil
Salman Al-Mahmood was a former Chief Scientific Officer at Gene Signal International SA, where he worked from 2000 to 2010.
He founded Gene Signal International SA in 2000.
Dr. Al-Mahmood has a graduate and doctorate degree from Université Nancy II.
Ehemalige bekannte Positionen von Salman Al-Mahmood
Unternehmen | Position | Ende |
---|---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Gründer | - |
Ausbildung von Salman Al-Mahmood
Université Nancy II | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |